Commentary by David Sutin MD, NYU Section 0f Geriatric Medicine
The Annual American Geriatric Society meeting, held May 2008, in Washington DC, was as usual fascinating. The meeting highlights included a lively discussion of the treatment of hypertension in the very elderly, and a talk on the emerging syndrome of …
Commentary by Antonella Surbone MD PhD FACP, Department of Medicine, New York University Medical School, Clinical Correlations Ethics Section Editor
According to the Institute of Medicine (IOM) report of April 14th, 2008, the elderly …
Commentary by Rachana Jani MD, PGY-2
As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study. So is this the new golden drug for …
Commentary by Danise Schiliro- Chuang MD
Welcome to this week’s edition of ShortCuts. Hoping as always that this post finds you all doing well. For those of you who have taken or who are about …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Matt Stein MS-4; …
Commentary by Judith Brenner MD, Associate Editor, Clinical Correlations. Reviewed by Valerie Peck MD, NYU Division of Endocrinology.
An 81 year old Caucasian woman with a history of diabetes and hypertension who was admitted to …
Commentary by Michael Poles MD, Associate Editor, Clinical Correlations
Well, it is early Saturday morning and I am sitting at my keyboard with coffee in hand. Gotta figure out what interesting tidbits from the world of medicine to …
Commentary by Peter Izmirly MD, NYU Division of Rheumatology
A 54 year old male with a past medical history significant for hepatitis C genotype 1a s/p ifn/ribavarin 2003-2004 with HCV Qual negative in 2005 presents with 3 weeks of bilateral …